Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market
HONG KONG SAR - EQS Newswire - 2 December 2024 - Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group") is pleased to announce two significant milestones that demonstrate the Group's continued growth and innovation in the field of medical aesthetics and dermatological solutions.